CardioComm Solutions, Inc. EKG.V

Company Overview

CardioComm Solutions, Inc. is a Canadian medical technology company focused on electrocardiogram (ECG) software, cardiac data management, and remote cardiac monitoring solutions. The company operates primarily in the digital health and cardiovascular diagnostics sectors, developing software platforms and connected technologies that enable physicians, hospitals, clinics, researchers, and monitoring providers to collect, analyze, store, and transmit cardiac rhythm data. CardioComm is publicly traded on the TSX Venture Exchange under the symbol EKG.V.

The company’s primary revenue drivers include its proprietary Global ECG Management System (GEMS) platform, software licensing, recurring service agreements, ECG data management services, and connected cardiac monitoring technologies. CardioComm has also commercialized consumer and clinical heart-monitoring solutions under the HeartCheck brand and has pursued partnerships with medical device manufacturers and healthcare technology providers to integrate ECG interpretation and connectivity capabilities. The company evolved from a software-centric ECG management provider into a broader remote cardiac monitoring and digital cardiology platform company as healthcare systems increasingly adopted telehealth and cloud-enabled diagnostics.

Business Operations

CardioComm’s operations are centered around software-enabled cardiac monitoring and diagnostic workflow management. Its principal business activities include ECG data acquisition, secure transmission, interpretation workflow support, archival management, and integration with healthcare information systems. The company’s core technology platform, Global ECG Management System (GEMS), is designed to support interoperability across multiple ECG device manufacturers and healthcare environments. Revenue is generated through software licensing, recurring maintenance contracts, subscription-based services, device sales, and professional integration services.

The company conducts operations primarily in Canada and the United States, while also supporting international customers and channel relationships in other healthcare markets. CardioComm has historically collaborated with device manufacturers, telemedicine providers, and healthcare institutions to expand the use of its ECG management technologies. Its assets are largely intellectual-property driven, including proprietary software platforms, regulatory-cleared cardiac technologies, and cloud-based ECG workflow capabilities. Public disclosures indicate ongoing efforts to expand remote patient monitoring applications and digital healthcare integrations tied to ambulatory cardiac diagnostics.

Strategic Position & Investments

CardioComm’s strategic direction has focused on expanding recurring software and remote monitoring revenue while strengthening its position in digital cardiology and connected healthcare. Growth initiatives have included cloud-based ECG services, integration with wearable and handheld cardiac devices, and broader adoption of telecardiology infrastructure. The company has also emphasized regulatory compliance and interoperability as differentiators, particularly in environments where healthcare providers require secure management of large volumes of diagnostic cardiac data.

The company has pursued commercial relationships and technology integrations intended to broaden adoption of HeartCheck products and the GEMS platform within clinical and consumer monitoring markets. Strategic emphasis has also been placed on remote patient monitoring and decentralized healthcare delivery models, reflecting broader industry trends toward home-based diagnostics and telehealth. While CardioComm remains smaller in scale relative to major cardiovascular device companies, its niche positioning in vendor-neutral ECG workflow management and software interoperability represents a notable competitive characteristic within specialized cardiac informatics markets.

Geographic Footprint

CardioComm is headquartered in Ontario, Canada, and maintains operational exposure across North America, particularly within the Canadian and U.S. healthcare sectors. The company’s technologies have been deployed in hospitals, clinics, research organizations, and monitoring environments that require centralized ECG data management and remote cardiac monitoring capabilities.

In addition to its domestic base, CardioComm has reported commercial relationships and software deployments extending into international healthcare markets through distributors, integration partners, and technology collaborations. Its market presence is primarily concentrated in developed healthcare systems where digital cardiology infrastructure, interoperability standards, and remote diagnostics adoption are established or expanding.

Leadership & Governance

CardioComm has historically been led by executives with backgrounds in healthcare technology, cardiac diagnostics, and software commercialization. Public company filings and investor materials identify leadership emphasis on regulatory compliance, scalable digital healthcare infrastructure, and recurring software-based revenue generation. The company’s governance structure reflects its status as a publicly traded Canadian healthcare technology issuer subject to applicable securities and disclosure requirements.

Key executives publicly associated with the company include:

• Etienne Grima – President and Chief Executive Officer
• Mina Grima – Chief Financial Officer

Data inconclusive based on available public sources regarding broader current executive leadership composition beyond principal officers consistently identified in company disclosures.